Aclaris Therapeutics (ACRS) Non-Current Assets (2014 - 2026)
Aclaris Therapeutics' Non-Current Assets was $81.93 million in Q2 2026, down 3.6% from $84.95 million a year earlier and down 7.4% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Aclaris Therapeutics came in at $64.14 million, down 32.0% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 37.0% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $94.38 million in FY2024 (+37.7%), $68.55 million in FY2023 (+197.4%), $23.05 million in FY2022 (-50.1%) and $46.18 million in FY2021 (+247.4%).
- Quarterly Non-Current Assets has moved between $11.06 million (Q3 2022) and $102.71 million (Q2 2023) over five years.
- Compared with a year earlier, Non-Current Assets has declined for three straight quarters, with growth averaging 28.7% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q3 2023 (growth of 761.6%); the worst was Q3 2022 (a decline of 80.8%).
- Per Business Quant data, ACRS's Non-Current Assets in the three quarters before Q2 2026 was $88.49 million (Q1 2026), $64.14 million (Q4 2025) and $74.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Aclaris Therapeutics | 759.25 Mn | 759.25 Mn | 1.41 Mn | 81.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 81.93 Mn |
| Mar 31, 2026 | 88.49 Mn |
| Dec 31, 2025 | 64.14 Mn |
| Sep 30, 2025 | 74.94 Mn |
| Jun 30, 2025 | 84.95 Mn |
| Mar 31, 2025 | 89.30 Mn |
| Dec 31, 2024 | 94.38 Mn |
| Sep 30, 2024 | 50.06 Mn |
| Jun 30, 2024 | 43.44 Mn |
| Mar 31, 2024 | 38.73 Mn |
| Dec 31, 2023 | 68.55 Mn |
| Sep 30, 2023 | 95.29 Mn |
| Jun 30, 2023 | 102.71 Mn |
| Mar 31, 2023 | 45.34 Mn |
| Dec 31, 2022 | 23.05 Mn |
| Sep 30, 2022 | 11.06 Mn |
| Jun 30, 2022 | 18.62 Mn |
| Mar 31, 2022 | 35.65 Mn |
| Dec 31, 2021 | 46.18 Mn |
| Sep 30, 2021 | 57.71 Mn |
API Access
Aclaris Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();